Myasthenia Gravis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You visited the neurology outpatient department at Peking Union Medical College Hospital (PUMCH) between September 30, 2022 and September 30, 2024.
- You have been diagnosed with myasthenia gravis.
- You have been followed up and monitored at PUMCH for more than 6 months.
- You have read, understood, and signed a consent form agreeing to take part in the study.
Who may not be able to join:
- You have other medical conditions that also cause muscle weakness, which would make it hard for doctors to assess your symptoms accurately (confirm with trial site).
- Your medical records about other conditions you have or medications you were taking are not available from the start of the study period or during follow-up.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yuzhou Guan, Peking Union Medical College Hospital
Phone: 8610-69155817
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Relapse of myasthenia gravis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.